Medicines promotion and inhibiting bone loss
| Type of medicine | n | % |
| Contributors to bone loss (CBL) | ||
| Anti-epileptic (AEDs) | 239 | 41.6 |
| Proton pump inhibitors | 146 | 25.4 |
| SSRI | 117 | 20.3 |
| Barbiturates | 19 | 3.3 |
| Lithium | 16 | 2.8 |
| Oral prednisolone | 5 | 0.9 |
| Tamoxifen | 2 | 0.3 |
| Methotrexate immunosuppressant | 2 | 0.3 |
| Anastrazole | 2 | 0.3 |
| Medroxyprogesterone | 2 | 0.3 |
| Taking one or more type of CBL medicine | ||
| Totals | 368 | 64.0 |
| Treatment for osteoporosis | ||
| Calcium and vitamin D | 123 | 21.4 |
| Bisphosphates | 41 | 7.1 |
| Calcium only | 15 | 2.6 |
| Desosumab | 8 | 1.4 |
| Teripartide | 1 | 0.2 |
| Taking one or more treatment medicine | ||
| Totals | 143 | 24.9 |
| Supplementation | ||
| Vitamin D only | 23 | 4.0 |
| Totals | 23 | 4.0 |
AEDs, antiepileptic medicines; SSRI, selective serotonin reuptake inhibitors.